Effects of ketamine on nicorandil induced ATP-sensitive potassium channel activity in cell line derived from rat aortic smooth muscle

Journal of Medical Investigation

Volumn 57, Issue 3-4, 2010, Pages 237-244

  Kawano, Takashi ^a   Tanaka, Katsuya ^a   Yinhua , ^a   Eguchi, Satoru ^a   Kawano, Hiroaki ^a   Takahashi, Akira ^a   Nakaya, Yutaka ^a   Oshita, Shuzo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Intravenous anesthetics; Ketamine; Nicorandil; Patch clamp configuration; Potassium channel

Indexed keywords

ADENOSINE DIPHOSPHATE MAGNESIUM; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLIBENCLAMIDE; KETAMINE; NICORANDIL;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENCY; FETUS; IC 50; NONHUMAN; PATCH CLAMP; RAT; SMOOTH MUSCLE FIBER; STEREOCHEMISTRY;

ANGINA; RATTUS;

EID: 78649676658     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.57.237     Document Type: Article

References (22)

1. + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol 274: C25-37, 1998
2. Brayden JE: Functional roles of Katp channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 29: 312-316, 2002
3. Taira N: Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 63: 18J-24J, 1989
4. IONA Study group: Effect of nicorandil on coronary events in patients with stable angina: the Impact of Nicorandil in Angina (IONA) randomised trial. Lancet 359: 1269-75, 2002
5. Kashimoto S, Seki M, Ishiguro T, Yoshioka H, Nagata O, Nishimura K, Kikuchi T, Yamada T, Iwade M, Omi A, Honda O, Sakamoto A, Ogihara Y, Fujimoto K, Nakaigawa Y, Kato J, Watanabe A, Nomura M, Takeda J: Nicorandil decreases cardiac events during and after non-cardiac surgery. J Clin Anesth 19: 44-48, 2007
6. Kawano T, Oshita S, Takahashi A, Tsutsumi Y, Tomiyama Y, Kitahata H, Kuroda Y, Nakaya Y: Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 100: 338-346, 2004
7. Kawano T, Oshita S, Takahashi A, Tsutsumi Y, Tomiyama Y, Kitahata H, Kuroda Y, Nakaya Y: Molecular mechanisms of the inhibitory effects of bupivacaine, levobupivacaine, and ropiva-caine on sarcolemmal adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Anesthesiology 101: 390-398, 2004
8. Kawano T, Oshita S, Takahashi A, Tsutsumi Y, Tanaka K, Tomiyama Y, Kitahata H, Nakaya Y: Molecular mechanisms underlying ketamine-mediated inhibition of sarcolemmal adenosine triphosphate-sensitive potassium channels. An-esthesiology 102: 93-101, 2005
9. + channel openers. Pharmacol Ther 85: 39-53, 2000
10. + channel. A comparison with pinacidil and lemakalim. Circ Res 69: 1152-8, 1991
11. + channels in cardiac muscle. Nature 305: 147-148, 1983
12. Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Seino S, Marbán E, Nakaya H: Role of sarcolemmal Katp channels in cardioprotection against ische-mia/reperfusion injury in mice. J Clin Invest 109: 509-516, 2002
13. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, Seino S: Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 8: 466-72, 2002
14. Chutkow WA, Pu J, Wheeler MT, Wada T, Makielski JC, Burant CF, McNally EM: Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 Katp channels. J Clin Invest 110: 203-208, 2002
15. Reich DL, Silvay G: Ketamine: An update on the first twenty - five years of clinical experience. Can J Anaesth 36: 186-197, 1989
16. Müllenheim J, Frässdorf J, Preckel B, Thämer V, Schlack W: Ketamine, but not S(+)-keta-mine, blocks ischemic preconditioning in rabbit hearts in vivo. Anesthesiology 94: 630-636, 2001
17. Müllenheim J, Rulands R, Wietschorke T, Frässdorf J, Preckel B, Schlack W: Late preconditioning is blocked by racemic ketamine, but not by S(+)-ketamine. Anesth Analg 93: 265-270, 2001
18. + channels in the rat aorta. Anesthe-siology 97: 882-886, 2002
19. Imagawa J, Baxter GF, Yellon DM: Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J Cardiovasc Pharmacol 31: 74-79, 1998
20. Davie CS, Standen NB: Enhancement of the vasorelaxant potency of nicorandil by metabolic inhibition and adenosine in the pig coronary artery. Cardiovasc Res 37: 791-798, 1998
21. Kaneko T, Saito Y, Hikawa Y, Yasuda K, Makita K: Dose-dependent prophylactic effect of nicorandil, an ATP - sensitive potassium channel opener, on intra-operative myocardial is-chaemia in patients undergoing major abdominal surgery. Br J Anaesth 86: 332-337, 2001
22. Quayle JM, Nelson MT, Standen NB: ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physio Rev 77: 1165-232, 1997